In partnership with our Founding Sponsor, LabCentral 238 is eager to launch the Astellas 2024 Speaker Series. The first iteration titled, Cell Therapy Manufacturing: Navigating CMC Development Challenges to Maximize Speed to the Clinic, will feature a presentation from the Astellas Institute of Regenerative Medicinefollowed by adiscussion with a diverse group of industry experts.
Please be sure to register today as space is limited!